Results: 1-11 |
Results: 11

Authors: Carew, JF Kooby, DA Halterman, MW Kim, SH Federoff, HJ Fong, YM
Citation: Jf. Carew et al., A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes, MOL THER, 4(3), 2001, pp. 250-256

Authors: Burt, BM Humm, JL Kooby, DA Squire, OD Mastorides, S Larson, SM Fong, YM
Citation: Bm. Burt et al., Using positron emission tomography with [F-18]FDG to predict tumor behavior in experimental colorectal cancer, NEOPLASIA, 3(3), 2001, pp. 189-195

Authors: Cozzi, PJ Malhotra, S Mcauliffe, P Kooby, DA Federoff, HJ Huryk, B Johnson, P Scardino, PT Heston, WDW Fong, Y
Citation: Pj. Cozzi et al., Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model, FASEB J, 15(7), 2001, pp. 1306-1308

Authors: Petrowsky, H Sturm, I Graubitz, O Kooby, DA Staib-Sebler, E Gog, C Kohne, CH Hillebrand, T Daniel, PT Fong, Y Lorenz, M
Citation: H. Petrowsky et al., Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases, EUR J SUR O, 27(1), 2001, pp. 80-87

Authors: Petrowsky, H Roberts, GD Kooby, DA Burt, BM Bennett, JJ Delman, KA Stanziale, SF Delohery, TM Tong, WP Federoff, HJ Fong, YM
Citation: H. Petrowsky et al., Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus, J VIROLOGY, 75(15), 2001, pp. 7050-7058

Authors: Delman, KA Bennett, JJ Zager, JS Burt, BM McAuliffe, PF Petrowsky, H Kooby, DA Hawkins, WG Horsburgh, BC Johnson, P Fong, Y
Citation: Ka. Delman et al., Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy, HUM GENE TH, 11(18), 2000, pp. 2465-2472

Authors: Bennett, JJ Kooby, DA Delman, K McAuliffe, P Halterman, MW Federoff, H Fong, YM
Citation: Jj. Bennett et al., Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer, J MOL MED-J, 78(3), 2000, pp. 166-174

Authors: Kim, SH Carew, JF Kooby, DA Shields, J Entwisle, C Patel, S Shah, JP Fong, YM
Citation: Sh. Kim et al., Combination gene therapy using multiple immunomodulatory genes transferredby a defective infectious single-cycle herpes virus in squamous cell cancer, CANC GENE T, 7(9), 2000, pp. 1279-1285

Authors: Kooby, DA Zakian, KL Challa, SN Matei, C Petrowsky, H Yoo, HH Koutcher, JA Fong, YM
Citation: Da. Kooby et al., Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determinesafe timing of chemotherapy after hepatic resection, CANCER RES, 60(14), 2000, pp. 3800-3806

Authors: Carew, JF Kooby, DA Halterman, MW Federoff, HJ Fong, YM
Citation: Jf. Carew et al., Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207), HUM GENE TH, 10(10), 1999, pp. 1599-1606

Authors: Kooby, DA Carew, JF Halterman, MW Mack, JE Bertino, JR Blumgart, LH Federoff, HJ Fong, YM
Citation: Da. Kooby et al., Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207), FASEB J, 13(11), 1999, pp. 1325-1334
Risultati: 1-11 |